The experimental study of the antihypoxic properties of harmine hydrochloride
https://doi.org/10.33647/2074-5982-17-2-71-78
Abstract
A derivative of the beta-carboline alkaloid harmine — the drug harmine hydrochloride was studied for the presence of antihypoxic properties in models of hypobaric hypoxia and normobaric hypoxia with hypercapnia. It was found that harmine hydrochloride does not have a signifi cant compensatory effect in the normobaric hypoxia test with hypercapnia. At the same time, harmine hydrochloride in small doses (2.5 and 5 mg/kg) has antihypoxic activity in the hypobaric hypoxia test, which is expressed in a statistically signifi cant increase in the life expectancy of animals treated with the drug, compared with the control, in conditions of hypoxia. According to the antihypoxic effect, harmine hydrochloride at doses of 2.5 and 5 mg/kg was found to be comparable with the reference drug (mexidol, 100 mg/kg).
About the Authors
S. M. AdekenovKazakhstan
Sergazy M. Adekenov, Dr. Sci. (Chem.), Prof., Acad. of the National Academy of Sciences of the Republic of Kazakhstan
100009, Karaganda, M. Gazalieva Str., 4
V. N. Karkischenko
Russian Federation
Vladislav N. Karkischenko, Dr. Sci. (Med.), Prof.
143442, Moscow Region, Krasnogorsk District, Svetlye Gory Village, 1
M. S. Nesterov
Russian Federation
Maxim S. Nesterov
143442, Moscow Region, Krasnogorsk District, Svetlye Gory Village, 1
D. A. Abaimov
Russian Federation
Denis A. Abaimov, Cand. Sci. (Biol.)
125367, Moscow, Volokolamskoe Highway, 80
A. K. Sariev
Russian Federation
Abrek K. Sariev, Dr. Sci. (Med.), Prof.
119991, Moscow, Trubetskaya Str., 8, building 2
References
1. Adekenov S.M., Nurmaganbetov Zh.S., Turmukhambetov A.Zh., Anayev A.A., Arystan L.I., Sariyev A.K. Primeneniye 7-metoksi-1-metil-9Hpirido[3,4-b]indol-2N-gidrokhlorida v kachestve antidepressivnogo, protivogipoksicheskogo i antiparkinsonicheskogo sredstva [Application of 7-methoxy-1-methyl-9H-pyrido [3,4-b] indole-2N-hydrochloride as an antidepressant, antihypoxic and antiparkinsonian agent]. Innovative patent of the Republic of Kazakhstan No. 29584. 2015. Byul. No. 3. (In Russian)].
2. Yeliseyev A.G., Gitun T. Bol’shaya meditsinskaya entsiklopediya [Great medical encyclopedia]. Moscow: DirektMedia Publ., 2005:1000. (In Russian)].
3. Okovitiy S.V., Gayvoronskaya V., Kulikov A., Shulenin S. Clinical pharmacology. Izbrannyye lektsii [Selected lectures]. Moscow: GEOTAR-Media Publ., 2009:608. (In Russian)].
4. Okovitiy S.V., Sukhanov D.S., Zaplutanov V.A., Smagina A.N. Antigipoksanty v sovremennoy klinicheskoy praktike [Antihypoxants in modern clinical practice]. Clinical medicine. 2012;90(9):63–68. (In Russian)].
5. Rukovodstvo po eksperimental’nomu (doklinicheskomu) izucheniyu novykh farmakologicheskikh veshchestv [Guidelines for experimental (preclinical) study of new pharmacological substances]. Ed. by R. Khabriyev, et al. Moscow: Meditsina Publ. 2005:832. (In Russian)].
6. Berrougui H., Isabelle M., Cloutier M., Hmamouchi M., Khalil A. Protective effects of Peganum harmala L. extract, harmine and harmaline against human lowdensity lipoprotein oxidation. J. Pharm. Pharmacol. 2006;58(7):967–974.
7. Li S.P., Wang Y.W., Qi S.L., Zhang Y.P., Deng G., Ding W.Z., Ma C., Lin Q.Y., Guan H.D., Liu W., Cheng X.M., Wang C.H. Analogous beta-carboline alkaloids harmaline and harmine ameliorate scopolamineinduced cognition dysfunction by attenuating acetylcholinesterase activity, oxidative stress, and infl ammation in mice. Front. Pharmacol. 2018;9:346.
8. Tse S.Y., Mak I.T., Dickens B.F. Antioxidative properties of harmane and beta-carboline alkaloids. Biochem. Pharmacol. 1991;42(3):459–464.
Review
For citations:
Adekenov S.M., Karkischenko V.N., Nesterov M.S., Abaimov D.A., Sariev A.K. The experimental study of the antihypoxic properties of harmine hydrochloride. Journal Biomed. 2021;17(2):71-78. (In Russ.) https://doi.org/10.33647/2074-5982-17-2-71-78